Federal Capture Intelligence

Top DoD pharmaceutical preparation manufacturing contractors (NAICS 325412)

Contract actions: October 1, 2021 – October 23, 2026 Updated October 24, 2026 Department of Defense agency guide NAICS 325412 · Pharmaceutical Preparation Manufacturing
Latest 12 months
$52.9M
Net obligations · Down $30.1M vs. $83.0M preceding
Prime contractors
72
With positive obligations in the latest 12 months

Research the DoD federal contracting market for pharmaceutical preparation manufacturing under NAICS 325412. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and observed contract vehicle usage.

Contract obligation trends for Pharmaceutical Preparation Manufacturing at the Department of Defense

Federal records show $26.3B in net obligations across 80,885 awards in Pharmaceutical Preparation Manufacturing at the Department of Defense from Oct 1, 2021 through Oct 23, 2026. This market accounts for 1.2% of $2.3T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 36.2% from $83.0M to $52.9M. 6 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY27 is year-to-date through Oct 23, 2026; earlier years show complete fiscal-year totals.

FY27 year-to-date: $0 versus $1.6M through the same date in FY26 (−100.0%).
Net obligations · complete fiscal yearNet obligations · FY27 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$24.0B18,496Complete
FY2023$2.0B16,837Complete
FY2024$116.4M17,387Complete
FY2025$89.0M23,694Complete
FY2026$54.5M9,254Complete

Market at a glance

All reported prime contract awards
All-period net obligations
$26.3B
80,885 awards · 219 prime contractors
Latest 12-month movement
−36.2%
$52.9M vs. $83.0M
Leading eight prime share
84.5%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
1.2% of $2.3T in agency-wide net obligations.
Set-aside share when reported
0.9% of 11,822 awards with reported set-aside status.
Set-aside reporting
110 set aside · 11,712 no set-aside · 69,063 not reported

What changed in the last 12 months?

Oct 24, 2025–Oct 23, 2026, compared with Oct 24, 2024–Oct 23, 2025.

Competitive shifts

NOVARTIS PHARMACEUTICALS CORPORATION climbed the most in the contractor rankings
#23→#3Up 20 places
The contractor accounts for 8.1% of positive obligations across 6 reported actions.
TEVA PHARMACEUTICALS USA, INC. had the largest decline in reported obligations
$40.2M→$21.9M−$18.3M
The contractor now ranks #1 by positive obligations and accounts for 41.3% of positive obligations, based on 21 reported actions.
AMERICAN REGENT INC fell the most in the contractor rankings
#6→#55Down 49 places
The contractor accounts for 0.020% of positive obligations across 18 reported actions.

Buyer demand

Reported obligations through DLA TROOP SUPPORT decreased
$47.1M→$22.8M−$24.2M
Latest-period activity spans 2,241 awards across 29 prime contractors.
Reported obligations through AMC BAMC FSH - MM increased
$3.0M→$5.9M+$2.9M
Latest-period activity spans 19 awards across 14 prime contractors.
How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Federal contract obligations by funding office

See how positive obligations were attributed across funding offices in the 12 months ending Oct 23, 2026.

43.2% of positive obligations were attributed to DLA TROOP SUPPORT (SPE2DP). That represents $22.8M, down $24.2M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. DLA TROOP SUPPORT (SPE2DP)43.2% · $22.8M · down $24.2M
  2. DLA TROOP SUPPORT (SPE2D6)21.4% · $11.3M · down $188K
  3. AMC BAMC FSH - MM11.1% · $5.9M · up $2.9M
  4. DIRECTOR, WRNMMC4.0% · $2.1M · down $686K
  5. AMC BEAUMONT BLISS - MM4.0% · $2.1M · up $1.1M
  6. All other reported offices16.3% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    DLA TROOP SUPPORT (SPE2DP)

    #1Rank unchanged

    Latest 12 months

    $22.8M

    43.2% of positive obligations

    Versus preceding 12 months

    −$24.2M

    29 active prime contractors · 2,241 awards

    View office comparison and evidence

    Reported obligations decreased 51.5% from $47.1M to $22.8M. The office’s share of positive obligations moved from 56.3% to 43.2%, a change of −13.2 percentage points.

    The latest period contains 2,246 actions across 2,241 awards and 7 newly active prime contractors. The preceding period contained 38 active prime contractors and 16,219 awards.

  2. Reported funding office

    DLA TROOP SUPPORT (SPE2D6)

    #2Rank unchanged

    Latest 12 months

    $11.3M

    21.4% of positive obligations

    Versus preceding 12 months

    −$188K

    1 active prime contractor · 103 awards

    View office comparison and evidence

    Reported obligations decreased 1.6% from $11.5M to $11.3M. The office’s share of positive obligations moved from 13.8% to 21.4%, a change of +7.6 percentage points.

    The latest period contains 103 actions across 103 awards. The preceding period contained 1 active prime contractor and 198 awards.

  3. Reported funding office

    AMC BAMC FSH - MM

    #3Up 2 from #5

    Latest 12 months

    $5.9M

    11.1% of positive obligations

    Versus preceding 12 months

    +$2.9M

    14 active prime contractors · 19 awards

    View office comparison and evidence

    Reported obligations increased 97.5% from $3.0M to $5.9M. The office’s share of positive obligations moved from 3.5% to 11.1%, a change of +7.5 percentage points.

    The latest period contains 37 actions across 19 awards and 2 newly active prime contractors. The preceding period contained 16 active prime contractors and 30 awards.

  4. Reported funding office

    DIRECTOR, WRNMMC

    #4Up 2 from #6

    Latest 12 months

    $2.1M

    4.0% of positive obligations

    Versus preceding 12 months

    −$686K

    10 active prime contractors · 11 awards

    View office comparison and evidence

    Reported obligations decreased 24.2% from $2.8M to $2.1M. The office’s share of positive obligations moved from 3.4% to 4.0%, a change of +0.7 percentage points.

    The latest period contains 12 actions across 11 awards and 2 newly active prime contractors. The preceding period contained 10 active prime contractors and 16 awards.

  5. Reported funding office

    AMC BEAUMONT BLISS - MM

    #5Up 6 from #11

    Latest 12 months

    $2.1M

    4.0% of positive obligations

    Versus preceding 12 months

    +$1.1M

    8 active prime contractors · 9 awards

    View office comparison and evidence

    Reported obligations increased 111.5% from $1.0M to $2.1M. The office’s share of positive obligations moved from 1.2% to 4.0%, a change of +2.8 percentage points.

    The latest period contains 14 actions across 9 awards. The preceding period contained 10 active prime contractors and 14 awards.

  6. Reported funding office

    KIMBROUGH AMB CC MEADE - MM

    #6Up 1 from #7

    Latest 12 months

    $1.2M

    2.2% of positive obligations

    Versus preceding 12 months

    −$513K

    2 active prime contractors · 3 awards

    View office comparison and evidence

    Reported obligations decreased 30.5% from $1.7M to $1.2M. The office’s share of positive obligations moved from 2.0% to 2.2%, a change of +0.2 percentage points.

    The latest period contains 4 actions across 3 awards. The preceding period contained 3 active prime contractors and 6 awards.

  7. Reported funding office

    AMC TRIPLER SHAFTER - MM

    #7New to the positive-obligation ranking

    Latest 12 months

    $1.0M

    2.0% of positive obligations

    Versus preceding 12 months

    +$1.3M

    5 active prime contractors · 7 awards

    View office comparison and evidence

    Reported obligations moved from $245K in net deobligations to $1.0M in net obligations. The office’s share of positive obligations moved from 0% to 2.0%, a change of +2.0 percentage points.

    The latest period contains 19 actions across 7 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 6 awards.

  8. Reported funding office

    DLA TROOP SUPPORT (SPE2D9)

    #8Rank unchanged

    Latest 12 months

    $925K

    1.8% of positive obligations

    Versus preceding 12 months

    −$525K

    1 active prime contractor · 4,986 awards

    View office comparison and evidence

    Reported obligations decreased 36.2% from $1.5M to $925K. The office’s share of positive obligations moved from 1.7% to 1.8%, a change of 0.0 percentage points.

    The latest period contains 4,986 actions across 4,986 awards. The preceding period contained 1 active prime contractor and 4,635 awards.

  9. Reported funding office

    NAV MED CNT PORTSMOUTH VA - MM

    #9Up 1 from #10

    Latest 12 months

    $767K

    1.4% of positive obligations

    Versus preceding 12 months

    −$285K

    4 active prime contractors · 5 awards

    View office comparison and evidence

    Reported obligations decreased 27.1% from $1.1M to $767K. The office’s share of positive obligations moved from 1.3% to 1.4%, a change of +0.2 percentage points.

    The latest period contains 7 actions across 5 awards. The preceding period contained 4 active prime contractors and 5 awards.

  10. Reported funding office

    AMC GORDON - PB

    #10Up 7 from #17

    Latest 12 months

    $570K

    1.1% of positive obligations

    Versus preceding 12 months

    +$327K

    3 active prime contractors · 3 awards

    View office comparison and evidence

    Reported obligations increased 134.8% from $243K to $570K. The office’s share of positive obligations moved from 0.29% to 1.1%, a change of +0.8 percentage points.

    The latest period contains 5 actions across 3 awards. The preceding period contained 4 active prime contractors and 5 awards.

  11. Reported funding office

    NAV MED CTR SAN DIEGO CA - MM

    #11Up 24 from #35

    Latest 12 months

    $554K

    1.1% of positive obligations

    Versus preceding 12 months

    +$510K

    2 active prime contractors · 3 awards

    View office comparison and evidence

    Reported obligations increased 1168.2% from $44K to $554K. The office’s share of positive obligations moved from 0.050% to 1.1%, a change of +1.0 percentage points.

    The latest period contains 5 actions across 3 awards and 1 newly active prime contractor. The preceding period contained 1 active prime contractor and 2 awards.

  12. Reported funding office

    DLA TROOP SUPPORT (SPE2D0)

    #15Down 12 from #3

    Latest 12 months

    $269K

    0.51% of positive obligations

    Versus preceding 12 months

    −$3.6M

    2 active prime contractors · 22 awards

    View office comparison and evidence

    Reported obligations decreased 93.1% from $3.9M to $269K. The office’s share of positive obligations moved from 4.7% to 0.51%, a change of −4.1 percentage points.

    The latest period contains 22 actions across 22 awards. The preceding period contained 8 active prime contractors and 47 awards.

  13. Reported funding office

    AMC HOOD - PA

    #18New to the positive-obligation ranking

    Latest 12 months

    $232K

    0.44% of positive obligations

    Versus preceding 12 months

    +$352K

    2 active prime contractors · 3 awards

    View office comparison and evidence

    Reported obligations moved from $120K in net deobligations to $232K in net obligations. The office’s share of positive obligations moved from 0% to 0.44%, a change of +0.4 percentage points.

    The latest period contains 9 actions across 3 awards. The preceding period contained 4 active prime contractors and 4 awards.

  14. Reported funding office

    FA4427 60 CONS LGC

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$720K

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $720K to $0. The office’s share of positive obligations moved from 0.86% to 0%, a change of −0.9 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 1 active prime contractor and 1 award.

  15. Reported funding office

    W6DZ CPE CBRND FT DETRICK

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$1.2M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $1.2M to $0. The office’s share of positive obligations moved from 1.5% to 0%, a change of −1.5 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 1 active prime contractor and 1 award.

  16. Reported funding office

    W2DN BROOKE AMC

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$3.8M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $3.8M to $0. The office’s share of positive obligations moved from 4.5% to 0%, a change of −4.5 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 2 active prime contractors and 2 awards.

Contract types, competition, and procurement methods

From Oct 24, 2025 through Oct 23, 2026, 6,582 awards had positive obligations totaling $53.6M. Only One Source was the leading reported procedure, accounting for 68.8% of positive obligations. Awards with a reported parent IDV accounted for 81.5%. Reported awards used contract vehicles such as VA FSS Schedule 65IB.

Leading award type
78.3%
Delivery Order
Leading reported procedure
68.8%
Only One Source
Reported parent IDV
81.5%
of positive obligations had a reported parent IDV
Median reported offers
2
859 of 6,582 awards reported offers · Limited reporting

Observed contract vehicles

Only exact reported parent-PIID matches are shown; missing parent IDs are not inferred.

Same-NAICS comparison

Compared with the NAICS 325412 peer median, parent-IDV obligation share is 16.9 percentage points lower, reported full-and-open obligation share is 35.2 percentage points lower, delivery-order obligation share is 20.0 percentage points lower, and median positive award obligations are 99.9% lower.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share81.5%98.4%-16.9 pts
Reported full-and-open obligation share5.8%41.0%-35.2 pts
Delivery-order obligation share78.3%98.3%-20.0 pts
Median positive award obligations$51$54K-99.9%
Peer cohort and comparison limits

The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Delivery Order(C)5,732$41.9M78.3%
Purchase Order(B)825$8.9M16.6%
BPA Call(A)22$1.7M3.3%
Definitive Contract(D)3$1.0M1.9%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
IDC(B)5,722$41.0M76.5%
BPA(E)22$1.7M3.3%
FSS(C)10$961K1.8%
Not reported828$9.9M18.5%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)5,744$42.7M79.7%
Multiple Award(M)10$961K1.8%
Not reported828$9.9M18.5%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Only One Source(SSS)129$36.9M68.8%
Simplified Acquisition(SP1)772$10.4M19.4%
Negotiated Proposal/Quote(NP)5,492$2.1M3.8%
Sss(ONLY ONE SOURCE)6$2.0M3.8%
Subject to Multiple Award Fair Opportunity(MAFO)11$1.2M2.3%
Np(NEGOTIATED PROPOSAL/QUOTE)71$828K1.6%
Other reported values101$160K0.30%

Extent competed

Reported valueAwardsPositive obligationsShare
Not Competed(C)30$27.4M51.1%
Not Available for Competition(B)99$9.5M17.7%
Not Competed Under SAP(G)65$5.6M10.5%
Competed Under SAP(F)707$4.8M9.0%
Full and Open Competition(A)5,502$3.1M5.8%
B(NOT AVAILABLE FOR COMPETITION)4$1.8M3.4%
Other reported values175$1.3M2.5%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Only One Source - Other(ONE)6$749K1.4%
Other Statutory Authority(OSA)1$245K0.46%
Fair Opportunity Given(FAIR)2$180K0.34%
FAR 16.505(B)(2)(I)(G) Single Source(SSRC)1$20K0.040%
FAR 16.505(B)(2)(I)(G) Limited Sources(LSRC)1$15K0.030%
Not reported6,571$52.4M97.7%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
Only One Source-Other (FAR 6.302-1 Other)(ONE)133$38.5M72.0%
SAP Non-Competition (FAR 13)(SP2)71$5.4M10.1%
Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH)1$182K0.34%
Unique Source (FAR 6.302-1(B)(1))(UNQ)1$177K0.33%
Urgency (FAR 6.302-2)(URG)1$168K0.31%
Not reported6,375$9.1M16.9%

Contract pricing types

Reported valueAwardsPositive obligationsShare
Firm Fixed Price(J)6,404$50.5M94.4%
J(FIRM FIXED PRICE)178$3.0M5.6%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
Drugs and Biologicals(6505)6,324$48.7M90.9%
Medical and Surgical Instruments, Equipment, and Supplies(6515)58$1.6M3.1%
Laboratory Equipment and Supplies(6640)6$1.2M2.3%
in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550)50$761K1.4%
Pharmacy Services(Q517)6$381K0.71%
Medical- Radiology(Q522)1$262K0.49%
Other reported values137$608K1.1%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
Defense Logistics Agency(97AS)6,480$36.4M68.0%
Department of the Army(2100)56$11.6M21.6%
Defense Health Agency(97DH)45$5.5M10.4%
U.S. Special Operations Command(97ZS)1$7K0.010%

Awarding offices

Reported valueAwardsPositive obligationsShare
Dla Troop Support(SPE2DP)738$23.5M43.8%
Dla Troop Support(SPE2D6)103$11.3M21.2%
W40m Mrc0 West(W81K00)37$9.4M17.5%
Defense Health Agency(HT0014)12$2.3M4.2%
Defense Health Agency Hcd West(HT9410)12$1.8M3.4%
W40m Usa Hca(W81K04)12$1.5M2.9%
Other reported values5,668$3.8M7.0%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
SPE2DP20D0002(9700)21$21.9M40.9%
SPE2DP23D0001(9700)103$11.3M21.2%
W81K0024D0004(9700)1$3.2M6.0%
SPE2DP21D0002(9700)3$1.2M2.2%
SPE2DX25D8022(9700)4,651$925K1.7%
HT940625DE001(9700)1$401K0.75%
V797D60737(3600)5$384K0.72%
HT001424A0002(9700)5$344K0.64%
Other reported values964$3.9M7.3%
Not reported828$9.9M18.5%

Exact vehicle-match evidence

Reported award data linked 1 award to a specific catalog vehicle.

Offers, award size, and timing

Median reported offers
2 median
859 reported · 5,723 not reported · Limited reporting
Positive award obligations
$51 median
$16–$185 middle 50%
Reported performance period
0 days median
6,582 reported · 0 not reported
Zero days means the reported start and current-end dates were the same.

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 23, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Top federal contractors

Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.

Prime contractor concentration
6 of 72prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
41.3%of positive obligations in the last 12 months
Leading four prime contractors
76.9%of positive obligations in the last 12 months
Leading eight prime contractors
84.5%of positive obligations in the last 12 months

Based on $53.1M in positive obligations during the 12 months ending Oct 23, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 24, 2024–Oct 23, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $21.9M

    41.3%

    Dollar movement

    −$18.3M

    vs. prior 12 months

    Last 12mo awards

    21 awards

    21 actions

    Historical and award details for TEVA PHARMACEUTICALS USA, INC.
    Obligations: prior → latest
    $40.2M → $21.9M
    −45.4%
    Share: prior → latest
    48.0% → 41.3%
    −6.7 percentage points
    All-period obligations
    $172.4M
    0.66% of all-period positive obligations · 332 awards
    Recorded activity
    Since Nov 9, 2021
    through Apr 15, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported2166
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $12.4M

    23.3%

    Dollar movement

    +$324K

    vs. prior 12 months

    Last 12mo awards

    107 awards

    107 actions

    Historical and award details for CANADIAN COMMERCIAL CORPORATION
    Obligations: prior → latest
    $12.0M → $12.4M
    +2.7%
    Share: prior → latest
    14.4% → 23.3%
    +8.9 percentage points
    All-period obligations
    $112.7M
    0.43% of all-period positive obligations · 1,040 awards
    Recorded activity
    Since Oct 6, 2021
    through Jul 20, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported107201
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $4.3M

    8.1%

    Dollar movement

    +$3.9M

    vs. prior 12 months

    Last 12mo awards

    4 awards

    6 actions

    Historical and award details for NOVARTIS PHARMACEUTICALS CORPORATION
    Obligations: prior → latest
    $426K → $4.3M
    +907.5%
    Share: prior → latest
    0.51% → 8.1%
    +7.6 percentage points
    All-period obligations
    $4.7M
    0.020% of all-period positive obligations · 6 awards
    Recorded activity
    Since Jul 1, 2025
    through Feb 11, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside21
    Not reported22
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $2.2M

    4.2%

    Dollar movement

    −$722K

    vs. prior 12 months

    Last 12mo awards

    16 awards

    21 actions

    Historical and award details for CARDINAL HEALTH 414, LLC
    Obligations: prior → latest
    $3.0M → $2.2M
    −24.4%
    Share: prior → latest
    3.5% → 4.2%
    +0.7 percentage points
    All-period obligations
    $14.5M
    0.060% of all-period positive obligations · 77 awards
    Recorded activity
    Since Oct 6, 2021
    through Apr 20, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside1216
    Not reported45
    Reported small business00
    All-period set-aside types

    None reported.

  5. #5

    Last 12mo obligations

    $1.2M

    2.2%

    Dollar movement

    +$108K

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for JUBILANT HOLLISTERSTIER LLC
    Obligations: prior → latest
    $1.0M → $1.2M
    +10.3%
    Share: prior → latest
    1.3% → 2.2%
    +0.9 percentage points
    All-period obligations
    $3.1M
    0.010% of all-period positive obligations · 1 award
    Recorded activity
    Since Sep 29, 2023
    through Apr 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  6. #6

    Last 12mo obligations

    $1.1M

    2.0%

    Dollar movement

    +$437K

    vs. prior 12 months

    Last 12mo awards

    5 awards

    11 actions

    Historical and award details for LANTHEUS MEDICAL IMAGING, INC.
    Obligations: prior → latest
    $625K → $1.1M
    +69.9%
    Share: prior → latest
    0.75% → 2.0%
    +1.3 percentage points
    All-period obligations
    $4.3M
    0.020% of all-period positive obligations · 32 awards
    Recorded activity
    Since Oct 7, 2021
    through Apr 16, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside12
    Reported no set-aside24
    Not reported21
    Reported small business44
    All-period set-aside types
    • 3 · Total small business
  7. #7

    Last 12mo obligations

    $925K

    1.7%

    Dollar movement

    −$525K

    vs. prior 12 months

    Last 12mo awards

    4,986 awards

    4,986 actions

    Historical and award details for CARDINAL HEALTH, INC.
    Obligations: prior → latest
    $1.5M → $925K
    −36.2%
    Share: prior → latest
    1.7% → 1.7%
    0.0 percentage points
    All-period obligations
    $7.5M
    0.030% of all-period positive obligations · 24,665 awards
    Recorded activity
    Since Oct 1, 2021
    through Jul 20, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported4,9864,635
    Reported small business00
    All-period set-aside types

    None reported.

  8. #8

    Last 12mo obligations

    $883K

    1.7%

    Dollar movement

    +$451K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    3 actions

    Historical and award details for BRACCO DIAGNOSTICS INC.
    Obligations: prior → latest
    $432K → $883K
    +104.2%
    Share: prior → latest
    0.52% → 1.7%
    +1.1 percentage points
    All-period obligations
    $1.7M
    0.010% of all-period positive obligations · 6 awards
    Recorded activity
    Since Dec 15, 2021
    through Dec 15, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $757K

    1.4%

    Dollar movement

    −$119K

    vs. prior 12 months

    Last 12mo awards

    4 awards

    8 actions

    Historical and award details for PETNET SOLUTIONS, INC.
    Obligations: prior → latest
    $876K → $757K
    −13.6%
    Share: prior → latest
    1.1% → 1.4%
    +0.4 percentage points
    All-period obligations
    $3.2M
    0.010% of all-period positive obligations · 26 awards
    Recorded activity
    Since Oct 1, 2021
    through Apr 3, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside411
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  10. #10

    Last 12mo obligations

    $704K

    1.3%

    Dollar movement

    −$638K

    vs. prior 12 months

    Last 12mo awards

    4 awards

    10 actions

    Historical and award details for BOSTON SCIENTIFIC CORP
    Obligations: prior → latest
    $1.3M → $704K
    −47.5%
    Share: prior → latest
    1.6% → 1.3%
    −0.3 percentage points
    All-period obligations
    $4.0M
    0.020% of all-period positive obligations · 19 awards
    Recorded activity
    Since Oct 27, 2021
    through Apr 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside24
    Not reported22
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $593K

    1.1%

    Dollar movement

    +$972K

    vs. prior 12 months

    Last 12mo awards

    1 award

    3 actions

    Historical and award details for HAMAMATSU/QUEEN'S PET IMAGING CENTER, LLC
    Obligations: prior → latest
    −$379K → $593K
    Not comparable
    Share: prior → latest
    0% → 1.1%
    +1.1 percentage points
    All-period obligations
    $981K
    0% of all-period positive obligations · 1 award
    Recorded activity
    Since Sep 23, 2024
    through Apr 2, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business11
    All-period set-aside types

    None reported.

  12. #12

    Last 12mo obligations

    $532K

    1.0%

    Dollar movement

    −$626K

    vs. prior 12 months

    Last 12mo awards

    6 awards

    7 actions

    Historical and award details for SOFIE CO.
    Obligations: prior → latest
    $1.2M → $532K
    −54.1%
    Share: prior → latest
    1.4% → 1.0%
    −0.4 percentage points
    All-period obligations
    $4.3M
    0.020% of all-period positive obligations · 57 awards
    Recorded activity
    Since Oct 1, 2021
    through Feb 4, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside613
    Not reported00
    Reported small business01
    All-period set-aside types

    None reported.

  13. #13

    Last 12mo obligations

    $531K

    1.0%

    Dollar movement

    +$531K

    vs. prior 12 months

    Last 12mo awards

    3 awards

    6 actions

    Historical and award details for AMERICAN NATIONAL SERVICES LLC
    Obligations: prior → latest
    $0 → $531K
    Not comparable
    Share: prior → latest
    0% → 1.0%
    +1.0 percentage points
    All-period obligations
    $2.5M
    0.010% of all-period positive obligations · 9 awards
    Recorded activity
    Since Nov 5, 2021
    through Apr 6, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside21
    Reported no set-aside00
    Not reported11
    Reported small business32
    All-period set-aside types
    • 2 · Total small business
  14. #14

    Last 12mo obligations

    $496K

    0.93%

    Dollar movement

    −$105K

    vs. prior 12 months

    Last 12mo awards

    8 awards

    20 actions

    Historical and award details for INO THERAPEUTICS LLC
    Obligations: prior → latest
    $601K → $496K
    −17.5%
    Share: prior → latest
    0.72% → 0.93%
    +0.2 percentage points
    All-period obligations
    $3.4M
    0.010% of all-period positive obligations · 23 awards
    Recorded activity
    Since Oct 18, 2021
    through Apr 15, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside22
    Not reported67
    Reported small business00
    All-period set-aside types

    None reported.

  15. #15

    Last 12mo obligations

    $431K

    0.81%

    Dollar movement

    −$189K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for CEPHEID
    Obligations: prior → latest
    $620K → $431K
    −30.4%
    Share: prior → latest
    0.74% → 0.81%
    +0.1 percentage points
    All-period obligations
    $2.6M
    0.010% of all-period positive obligations · 1 award
    Recorded activity
    Since Oct 8, 2021
    through Dec 22, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

Recent federal contract award activity

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Modification

This action

+$3.2M

NOVARTIS PHARMACEUTICALS CORPORATION

AMC BAMC FSH - MM

LUTATHERA AND PLUVICTO - FY26 FUNDING FOR CLINS 0001 AND 0002 FOR POP DATE FROM 1OCT25 TO 30 SEPT 26.

Why it stands out

The contractor climbed 20 positions in this market.

It now ranks #3 by positive obligations over the latest 12 months.

Award net obligations
$3.2M
Share of 12-month positive obligations
6.0%
Supporting data
Prime contractor
#3 · 8.1% share
up 20 ranks · +7.6 percentage points · $3.9M net increase; action accounted for 82.1%
Funding office
#3 · 11.1% attributed share
up 2 ranks · +7.5 percentage points · $2.9M net increase; action exceeded it by $279K
PIID W81K0025FA195 · Mod P00002
Base award

This action

+$5.2M

CANADIAN COMMERCIAL CORPORATION

DLA TROOP SUPPORT

4571290114!REACTIVE SKIN DECONTAMINATION LOTION

Why it stands out

One action represented 9.8% of the market’s latest 12-month positive obligations.

At $5.2M, the action was large enough to materially affect the latest 12-month market picture.

Award net obligations
$5.2M
Share of 12-month positive obligations
9.8%
Supporting data
Funding office
#2 · 21.4% attributed share
$188K net decline despite this positive action
PIID SPE2D626F6F83
Base award

This action

+$4.0M

TEVA PHARMACEUTICALS USA, INC.

DLA TROOP SUPPORT

8511984334!ADENOVIRUS TYPE 4 A

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 7.4% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $18.3M overall.

Award net obligations
$4.0M
Share of 12-month positive obligations
7.4%
Supporting data
Prime contractor
#1 · 41.3% share
$18.3M net decline despite this positive action
Funding office
#1 · 43.2% attributed share
$24.2M net decline despite this positive action
PIID SPE2DP26F3586
Modification

This action

+$593K

HAMAMATSU/QUEEN'S PET IMAGING CENTER, LLC

AMC TRIPLER SHAFTER - MM

FDG-18 FOR TAMC, HAWAII.

Why it stands out

The award grew alongside stronger contractor activity.

The modification added $593K while contractor obligations rose $972K overall.

Award net obligations
$981K
Share of 12-month positive obligations
1.1%
Supporting data
Prime contractor
#11 · 1.1% share
+1.1 percentage points · $972K net increase; action accounted for 61.0%
Funding office
#7 · 2.0% attributed share
+2.0 percentage points · $1.3M net increase; action accounted for 46.2%
PIID W81K0224P0077 · Mod P00005
Modification

This action

+$864K

JUBILANT HOLLISTERSTIER LLC

KIMBROUGH AMB CC MEADE - MM

ANTIVENOM IMMUNOTHERAPY SUPPLIES

Why it stands out

This award grew while spending attributed to its office declined.

The modification added $864K while office-attributed obligations fell $513K overall.

Award net obligations
$3.1M
Share of 12-month positive obligations
1.6%
Supporting data
Funding office
#6 · 2.2% attributed share
$513K net decline despite this positive action
PIID W91YTZ23P0137 · Mod P00008
Modification

This action

+$553K

BOSTON SCIENTIFIC CORP

AMC BAMC FSH - MM

TRANSARTERIAL RADIOEMBOLIZATION USING YTTRIUM-90 MICROSPHERES IS A THERAPEUTIC OPTION FOR PATIENTS WITH INTERMEDIATE-OR ADVANCED-STAGE HEPATOCELLULAR CARCINOMA, INCLUDING THOSE WITH RECURRENT OR INOPERABLE HEPATOCELLULAR CARCINOMA.

Why it stands out

The funding office climbed 2 positions in attributed spending.

It now ranks #3 in attributed spending.

Award net obligations
$553K
Share of 12-month positive obligations
1.0%
Supporting data
Prime contractor
#10 · 1.3% share
$638K net decline despite this positive action
PIID W81K0025PA252 · Mod P00002
View recent award activity by date (10)
  1. Action+$304
    Award net obligations$304
  2. Action+$243
    Award net obligations$243
  3. Action+$2K
    Award net obligations$2K
  4. Action+$2K
    Award net obligations$2K
  5. Action+$17
    Award net obligations$17
  6. Action+$17
    Award net obligations$17
  7. Action+$180
    Award net obligations$180
  8. Action+$6K
    Award net obligations$6K
  9. Action+$53
    Award net obligations$53
  10. Action+$25
    Award net obligations$25

DoD pharmaceutical preparation manufacturing market FAQs

Answers based on reported federal contract data.

Who are the top DoD pharmaceutical preparation manufacturing contractors?

In the 12 months through October 23, 2026, TEVA PHARMACEUTICALS USA, INC., CANADIAN COMMERCIAL CORPORATION, and NOVARTIS PHARMACEUTICALS CORPORATION were the leading DoD pharmaceutical preparation manufacturing prime contractors by positive obligations.

  1. #1

    TEVA PHARMACEUTICALS USA, INC.

    $21,926,233 in positive obligations

  2. #2

    CANADIAN COMMERCIAL CORPORATION

    $12,359,869 in positive obligations

  3. #3

    NOVARTIS PHARMACEUTICALS CORPORATION

    $4,292,412 in positive obligations

Rankings use reported USAspending award data.

Did DoD contract obligations decrease in the pharmaceutical preparation manufacturing market?

Yes. Measured by net prime contract obligations, reported DoD activity in the pharmaceutical preparation manufacturing market decreased 36.2% from $83,029,440 in the preceding 12 months to $52,933,038 in the 12 months through October 23, 2026.

Latest 12 months
$52,933,038
Net prime contract obligations
Preceding 12 months
$83,029,440
Net prime contract obligations
Change
−36.2%
Between matched 12-month periods

Reported contract actions, not outlays or a forecast.

What recent DoD contract award activity was reported in the pharmaceutical preparation manufacturing market?

Recent DoD contract award activity reported in the pharmaceutical preparation manufacturing market included actions for NOVARTIS PHARMACEUTICALS CORPORATION, CANADIAN COMMERCIAL CORPORATION, and TEVA PHARMACEUTICALS USA, INC. during the 12 months through October 23, 2026.

Action obligations are transaction-level amounts, not current award-level obligations.

Which procurement methods were reported for DoD contracts under NAICS 325412?

From October 24, 2025 through October 23, 2026, DoD reported 6,582 positive-obligation awards for pharmaceutical preparation manufacturing under NAICS 325412. The leading award type was delivery order. The leading reported procedure was only one source.

Positive-obligation awards
6,582
Leading reported procedure
Only One Source
68.8% of positive obligations
Leading award type
Delivery Order
78.3% of positive obligations
Full and open
5.8%
of positive obligations
Reported parent IDV
81.5%
of positive obligations
Observed vehicles
VA FSS Schedule 65IB
Exact matches from reported parent PIIDs

Percentages use positive obligations as the denominator.

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Reported obligations include contract actions from October 1, 2021 through October 23, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.

Review data methodology